Bioengineering Early CNS Morphogenesis for a Scalable Neural Tube Defect Risk Assay

Randolph Ashton, Ph.D.
Southern California Stem Cell Consortium (SCSCC)
Randolph Ashton, Ph.D. profile photo

Date and time

May 13, 2021

9:30 AM - 10:30 AM PT



“Breaking News in Stem Cells” is the only lecture series that brings the top papers in the field to your desktop as they happen

This month, Randolph Ashton, Ph.D., will present.


Hosted by:

Evan Snyder, M.D., Ph.D.
Human Genetics Program
Director for Center for Stem Cells and Regenerative Medicine
Sanford Children’s Health Research Center


Randolph Ashton, Ph.D.
Associate Professor
Biomedical Engineering
Wisconsin Institute for Discovery

Associate Director
Stem Cell & Regenerative Medicine Center
University of Wisconsin–Madison

Dr. Ashton’s lab develops novel tissue engineering methodologies to derive brain and spinal cord tissues from human pluripotent stem cells, which can be used to create groundbreaking regenerative therapies and models of neurological disorders.

The Ashton Group's goal is to understand, model, and recapitulate in vitro the instructive signals utilized by human embryos to pattern tissue-specific differentiation of pluripotent stem cells, and apply this knowledge towards the rational design of tissue engineered scaffolds and other regenerative therapeutic strategies. Currently, we primarily focus on generating tissues and therapies for the central nervous system.